Insights

Extrachromosomal DNA Focus Boundless Bio specializes in developing cancer therapeutics targeting extrachromosomal DNA (ecDNA) to combat tumorigenesis, resistance, and recurrence. This unique approach may be leveraged as a selling point to pharmaceutical companies seeking innovative oncology solutions.

Leadership Appointments Recent appointments of key personnel like the Chief Medical Officer and Chief Financial Officer highlight Boundless Bio's commitment to assembling a strong team. Emphasizing the expertise and experience of these leaders can enhance credibility during sales pitches.

Financial Health and Funding With a revenue range of $10M - $50M and recent funding of $100M, Boundless Bio demonstrates financial stability and growth potential. This financial backing can instill confidence in potential partners or investors looking to collaborate with a stable and promising biotech company.

Market Presence and Public Offering Having gone public and receiving substantial media coverage, Boundless Bio has already gained recognition in the market. Leveraging this visibility as a market player can help in attracting interest from healthcare providers and investors seeking investment opportunities in the biotechnology sector.

Investment and Expansion Recent financing of $100M and ongoing developmental work, including a new ecDNA program, signal Boundless Bio's growth trajectory. Highlighting these investments and expansion plans can spark interest among potential collaborators looking to invest in cutting-edge oncology research and development.

Boundless Bio Tech Stack

Boundless Bio uses 8 technology products and services including MySQL, NetSuite, Google Cloud, and more. Explore Boundless Bio's tech stack below.

  • MySQL
    Database
  • NetSuite
    E-commerce
  • Google Cloud
    Infrastructure As A Service
  • TweenMax
    Javascript Frameworks
  • WP Engine
    Platform As A Service
  • PHP
    Programming Languages
  • Perl
    Programming Languages
  • Java
    Programming Languages

Media & News

Boundless Bio's Email Address Formats

Boundless Bio uses at least 1 format(s):
Boundless Bio Email FormatsExamplePercentage
FLast@boundlessbio.comJDoe@boundlessbio.com
72%
Last@boundlessbio.comDoe@boundlessbio.com
26%
FirstLast@boundlessbio.comJohnDoe@boundlessbio.com
1%
First.Last@boundlessbio.comJohn.Doe@boundlessbio.com
1%

Frequently Asked Questions

Where is Boundless Bio's headquarters located?

Minus sign iconPlus sign icon
Boundless Bio's main headquarters is located at 10955 Alexandria Way Suite 100 San Diego, CA 92121 US. The company has employees across 2 continents, including North AmericaEurope.

What is Boundless Bio's stock symbol?

Minus sign iconPlus sign icon
Boundless Bio is a publicly traded company; the company's stock symbol is BOLD.

What is Boundless Bio's official website and social media links?

Minus sign iconPlus sign icon
Boundless Bio's official website is boundlessbio.com and has social profiles on LinkedIn.

How much revenue does Boundless Bio generate?

Minus sign iconPlus sign icon
As of April 2025, Boundless Bio's annual revenue reached $15M.

What is Boundless Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Boundless Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Boundless Bio have currently?

Minus sign iconPlus sign icon
As of April 2025, Boundless Bio has approximately 82 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer And President: Z. H.Chief Medical Officer: R. C. D.Chief Legal Officer, Corporate Secretary; Head Of Quality: J. O.. Explore Boundless Bio's employee directory with LeadIQ.

What industry does Boundless Bio belong to?

Minus sign iconPlus sign icon
Boundless Bio operates in the Biotechnology Research industry.

What technology does Boundless Bio use?

Minus sign iconPlus sign icon
Boundless Bio's tech stack includes MySQLNetSuiteGoogle CloudTweenMaxWP EnginePHPPerlJava.

What is Boundless Bio's email format?

Minus sign iconPlus sign icon
Boundless Bio's email format typically follows the pattern of . Find more Boundless Bio email formats with LeadIQ.

How much funding has Boundless Bio raised to date?

Minus sign iconPlus sign icon
As of April 2025, Boundless Bio has raised $100M in funding. The last funding round occurred on May 16, 2023 for $100M.
Boundless Bio

Boundless Bio

Biotechnology ResearchCalifornia, United States51-200 Employees

Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence.

When DNA in cancer cells comes off chromosomes, “extrachromosomal DNA (ecDNA),” it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes,  driving cancer cells to grow and allowing them to resist treatment.  At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells’ ability to employ ecDNA to survive.

Our Culture:

At Boundless, you’ll experience what it means to be out in front of the wave. 
Our unprecedented science takes us to new shores, and our team navigates the best breaks. We’re leaders in our field, and we’re dedicated to the cause of understanding and treating intractable cancers.

Every employee at Boundless makes an unbridled impact on our capabilities and our culture. We’ll help you expand your abilities and defy your bounds by providing meaningful work and unbounded opportunities. Career development is essential at Boundless. 

We’re all in on this fight against cancer– collaboration is requisite to our success. We have a team of people who ask, offer, and accept help without regard for ego. We know that receiving support is energizing, and giving help is fulfilling. We are inspired by the patients who are reliant upon our success. 

At Boundless, we’re all in. We are unbound by convention, bound to save lives. 


Career Inquiries
careers@boundlessbio.com

General Information Inquiries
info@boundlessbio.com

Section iconCompany Overview

Headquarters
10955 Alexandria Way Suite 100 San Diego, CA 92121 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BOLD
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $100M

    Boundless Bio has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 16, 2023 in the amount of $100M.

  • $10M$50M

    Boundless Bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $100M

    Boundless Bio has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 16, 2023 in the amount of $100M.

  • $10M$50M

    Boundless Bio's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.